"Study Confirms PrEP as Highly Effective HIV Prevention Drug"

A study of 24,000 people in England has confirmed that PrEP (pre-exposure prophylaxis), a drug that prevents HIV infection, is highly effective as a real-world preventative treatment. The study, conducted at sexual health clinics across England, found that PrEP reduced the chances of getting HIV by 86%. The results have been described as "reassuring" and highlight the need for easier access to the drug, particularly among women and minority groups. The UK Health Security Agency (UKHSA) believes that increasing the uptake of PrEP will help achieve the government's goal of zero HIV transmissions by 2030.